• Mashup Score: 0
    EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update - 3 year(s) ago

    The rationale for the quest to close the left atrial appendage (LAA) for stroke prevention is composed of three elements: the concept that atrial fibrillation (

    Source: OUP Academic
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ESC_Journals
      ESC_Journals

      20/24 ⁉️Another question to be answered: 🤔 Is #LAAO better than, or at least as safe and effective as antithrombotic agents? Without a doubt, ongoing studies 📌 OCCLUSION-AF 📌 STROKE-CLOSE 📌 CLOSURE-AF 📌 ASAP-TOO will provide essential insights. https://t.co/2ZwUn9mlrY https://t.co/kGSLDc3qIG

    • Profile photo of ESC_Journals
      ESC_Journals

      17/24 #LAAO to who? 🎯 High-risk non-valvular #AF patients who ‘ve contraindications or can't tolerate long-term #OAC. 🎯 Patients w/elevated bleeding risk 🎯 Patients suffering from stroke while on #OAC 🎯 Patients unwilling to receive #OAC https://t.co/2ZwUn9mlrY https://t.co/smne72J9Do

    • Profile photo of ESC_Journals
      ESC_Journals

      14/24 📌 Please find step by step Amulet device deployment + tug test in the ⬇️ videos. 1st video ➡️ ‘ball’ & ‘triangle’ configuration of the ‘lobe’ 2nd video ➡️ ‘disc’ deployment 3rd video ➡️ tug test https://t.co/2ZwUn9mlrY https://t.co/BmQC7HaefV

    • Profile photo of ESC_Journals
      ESC_Journals

      13/24 📌Amulet device deployment has 4️⃣ steps: 1 > Unsheat for ‘ball’ configuration 2-3 > Advance delivery cable for ‘triangle’ configuration and ‘lobe’ unfolded 4 > Unsheat for ‘Disc’ unfolded 🎯 Lobe of the device should sit landing zone. https://t.co/2ZwUn9mlrY https://t.co/nzhG5v8wBh

    • Profile photo of ESC_Journals
      ESC_Journals

      5/24 🎯 Pre- & peri- & post-procedural imaging w/ #TEE and #yesCT is key for: 👉 Ruling out #LAA thrombus 👉 #LAA anatomy & dimensions 👉 Equipment (device) selection 👉 Guiding procedural device implantation 👉 Device surveillance post-implantation https://t.co/2ZwUn9mlrY https://t.co/b8IT8vd3CL

    • Profile photo of ESC_Journals
      ESC_Journals

      3/24 #LAA closure devices should be safe, efficent and easy to deploy. 📌 Currently available catheter-based devices for #LAAO have different principles. A- Plug ➡️ Watchman B- Pacifier ➡️ Amplatzer Amulet C- Ligation ➡️ Lariat https://t.co/2ZwUn9mlrY https://t.co/NZaX43x8qZ

    • Profile photo of ESC_Journals
      ESC_Journals

      2/24 🎯 The rationale of #LAAO 🔸 In non-valvular #AF patients, 90% of thrombus is located in the #LAA 🔸 These thrombi embolise to the 🧠 & cause #stroke 🎯 Don't miss the ‘#EHRA_ESC #EAPCI expert consensus document on catheter-based #LAAO –an update’ https://t.co/2ZwUn9mlrY https://t.co/rk3M26M5Lj

  • Mashup Score: 5
    Icosapent ethyl reduces coronary plaque at 18 months: EVAPORATE final results - 4 year(s) ago

    Icosapent ethyl as an adjunct to statin therapy significantly reduced multiple plaque components, including low-attenuation plaque, at 18 months, compared with placebo, according to final results of the EVAPORATE trial.The findings build on previously reported interim data that demonstrated a very early effect of icosapent ethyl (Vascepa, Amarin) on plaque volume at 9 months, with sustained and

    Source: www.healio.com
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DLBHATTMD
      DLBHATTMD

      Icosapent ethyl reduces coronary plaque at 18 months: EVAPORATE final results https://t.co/6UAvGmnCzo #cardiotwitter #cardiology #YesCT @Heart_SCCT @BudoffMd @SuvasiniL @cshekarMD @Katie_Kalvaitis